Envveno Medical Corp Stock Revenue
| NVNO Stock | USD 3.33 0.03 0.91% |
enVVeno Medical Corp fundamentals help investors to digest information that contributes to EnVVeno Medical's financial success or failures. It also enables traders to predict the movement of EnVVeno Stock. The fundamental analysis module provides a way to measure EnVVeno Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EnVVeno Medical stock.
| Last Reported | Projected for Next Year |
EnVVeno | Revenue |
enVVeno Medical Corp Company Revenue Analysis
EnVVeno Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of EnVVeno
Projected quarterly revenue analysis of enVVeno Medical Corp provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of EnVVeno Medical match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in EnVVeno Medical's stock price.
EnVVeno Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for EnVVeno Medical is extremely important. It helps to project a fair market value of EnVVeno Stock properly, considering its historical fundamentals such as Revenue. Since EnVVeno Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EnVVeno Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EnVVeno Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
EnVVeno Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, enVVeno Medical Corp reported 0.0 of revenue. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
EnVVeno Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EnVVeno Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EnVVeno Medical could also be used in its relative valuation, which is a method of valuing EnVVeno Medical by comparing valuation metrics of similar companies.EnVVeno Medical is currently under evaluation in revenue category among its peers.
EnVVeno Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of EnVVeno Medical from analyzing EnVVeno Medical's financial statements. These drivers represent accounts that assess EnVVeno Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of EnVVeno Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 8.7M | 11.2M | 57.2M | 57.3M | 63.2M | 66.4M | |
| Enterprise Value | 8.2M | 2.7M | 4.5M | 54.4M | 61.0M | 64.1M |
EnVVeno Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EnVVeno Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EnVVeno Medical's managers, analysts, and investors.Environmental | Governance | Social |
EnVVeno Medical Institutional Holders
Institutional Holdings refers to the ownership stake in EnVVeno Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of EnVVeno Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing EnVVeno Medical's value.| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 33.2 K | Laird Norton Tyee Trust Co | 2024-06-30 | 33 K | Fermata Advisors, Llc | 2024-09-30 | 30.2 K | State Street Corp | 2024-06-30 | 26.5 K | Ubs Group Ag | 2024-06-30 | 16.8 K | Arthur M. Cohen & Associates Llc | 2024-09-30 | 14 K | Tamar Securities, Llc | 2024-09-30 | 14 K | Citadel Advisors Llc | 2024-06-30 | 7.1 K | Tower Research Capital Llc | 2024-06-30 | 2.4 K | Nantahala Capital Management, Llc | 2024-06-30 | 955.7 K | Perceptive Advisors Llc | 2024-09-30 | 694.3 K |
EnVVeno Fundamentals
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | 10.64 M | ||||
| Shares Outstanding | 17.54 M | ||||
| Shares Owned By Insiders | 0.29 % | ||||
| Shares Owned By Institutions | 29.76 % | ||||
| Number Of Shares Shorted | 507.89 K | ||||
| Price To Book | 1.22 X | ||||
| EBITDA | (25.02 M) | ||||
| Net Income | (23.52 M) | ||||
| Cash And Equivalents | 37.48 M | ||||
| Cash Per Share | 3.96 X | ||||
| Total Debt | 1.4 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 20.79 X | ||||
| Book Value Per Share | 2.70 X | ||||
| Cash Flow From Operations | (18.86 M) | ||||
| Short Ratio | 3.63 X | ||||
| Earnings Per Share | (1.29) X | ||||
| Target Price | 18.0 | ||||
| Number Of Employees | 31 | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 57.87 M | ||||
| Total Asset | 48.63 M | ||||
| Retained Earnings | (130.04 M) | ||||
| Working Capital | 45.55 M | ||||
| Net Asset | 48.63 M |
About EnVVeno Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze enVVeno Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EnVVeno Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of enVVeno Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with EnVVeno Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.Moving against EnVVeno Stock
| 0.78 | VMD | Viemed Healthcare | PairCorr |
| 0.63 | DOCS | Doximity | PairCorr |
| 0.41 | ITGR | Integer Holdings Corp | PairCorr |
| 0.4 | SSY | SunLink Health Systems | PairCorr |
| 0.36 | CVS | CVS Health Corp Aggressive Push | PairCorr |
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out EnVVeno Medical Piotroski F Score and EnVVeno Medical Altman Z Score analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.37) | Return On Equity (0.59) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.